Comparison of alemtuzumab, anti-thymocyte globulin, and post-transplant cyclophosphamide for graft-versus-host disease and graft-versus-leukemia in murine models

Graft-versus-host disease is a major complication after allogeneic hematopoietic stem cell transplantation for hematological malignancies. Immunosuppressive drugs, such as anti-thymocyte globulin, alemtuzumab, and post-transplant cyclophosphamide, have been used to prevent graft-versus-host disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Mashima, Kiyomi, Oh, Iekuni, Fujiwara, Ken, Izawa, Junko, Takayama, Norihito, Nakano, Hirofumi, Kawasaki, Yasufumi, Minakata, Daisuke, Yamasaki, Ryoko, Morita, Kaoru, Ashizawa, Masahiro, Yamamoto, Chihiro, Hatano, Kaoru, Sato, Kazuya, Ohmine, Ken, Fujiwara, Shin-Ichiro, Ohno, Nobuhiko, Kanda, Yoshinobu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7799789/
https://www.ncbi.nlm.nih.gov/pubmed/33428661
http://dx.doi.org/10.1371/journal.pone.0245232

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7799789/
https://www.ncbi.nlm.nih.gov/pubmed/33428661
http://dx.doi.org/10.1371/journal.pone.0245232

Ejemplares similares